Investing in MegaTrends

GenIP announced the launch of a new AI-powered product and its first client for the new product, a Big Four accountancy firm.

What are professional investors asking AI about during the current market turbulence and how will that define Wall Street in the future?

The AI-powered investment intelligence platform has entered the Gulf region after securing an operational license from the DIFC.

VERAXA plans major RTO in the US, Congress gets shirty with banks over CATL, and Zopa CEO pauses US IPO plans.

Leading investor in robotics and AI stocks says tariffs will not sink NVIDIA but that investors need to "fasten their seat belts".

In IPO news this week, we look at Trump endorsed Newsmax, pharma play Aspargo Labs and US mobile banking provider, Chime Financial

Within a few years, Pila Pharma aims to be acquired by or partner with an industry player like Novo Nordisk.

One of the main factors is concern over energy efficiency regulations in China, which could affect the sale of NVIDIA's AI chips.

Wellnex Life IPOs on AIM, raising £5.2m to pay off debt, convertible notes and invest in product development and international expansion.

Klarna files for NYSE IPO after return to profit, Stada postpones mega German listing, and Quantum Base is coming to AIM.

CoreWeave cuts deal with Open AI ahead of anticipated IPO, Hinge Health files in New York and Venture Global craters.

Which Canadian stocks look like they can weather the trade war with the US while still providing investors with a decent return in 2025?

The Worldwide Healthcare Trust celebrates 30 years this year but it's the next 30 years that look really exciting

DeepSeek has rewritten the rules of the game for financial services companies and asks big questions about open source technology

One Health to transition from Aquis to AIM in March seeking greater liquidity as raises £8m to build its first surgical hub

Tristel sees strong performance as it continues to focus on opening up new high-growth overseas markets under new CEO Matt Sassone

Feedback hopes capital reorganisation and new funding will help flagship product, Bleepa's penetration into NHS. Buoyed by inclusion in ERF.

UK life sciencies stock ProBiotix Health has secured what it is calling an important new supply agreement in East Asia.

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis.

Shares in Novo Nordisk were slumping over 2H of 2024, but has this now created a buying opportunity for investors?

Avon Protection looks like one of the best quality stocks on the LSE at the moment, driven partly by fund manager love.

Investors are worried what further impact DeepSeek's technology will have on Nvidia's stock price - can NVDA bounce back?

US stock investors turning bearish as Chinese company mounts challenge to NVIDIA's supremacy with cheaper AI solution.

This tiny Canadian company is developing a next generation generator that could be the answer to power demands at data centers.

Bitcoin mania and bullishness in the artificial intelligence sector saw UK traders increase their positions in some popular stocks.

Nvidia disappointed investors with its presentation in Las Vegas this month, but there are positive implications for other sectors here.

Association of Investment Companies' members tip healthcare, technology and North America as the best-performing sectors for 2025

Seven & i holdings in Japan considers IPO of US assets, biotech companies could be coming back to the market, and a Chicago casino.

We take a closer look at Spectrum X, a UK biotech company which could list next year, and is currently taking on pre-IPO investment.

Benchmark has had a challenging year, but the disposal of its Genetics division sparks a new direction and return of capital to shareholders

Pila Pharma's stock has been bid up over 140% since the start of the year as it pushes ahead with research into Type 2 diabetes treatment.

Saxo Bank has published its annual list of outrageous predictions for 2025 to illustrate some of the uncertainties that could affect markets

Monzo CFO appointment sparks IPO expectations, CoreWeave aims for $35bn valuation in 2025 IPO, Odyssey Therapeutics meets investors pre-IPO.

This AIM-listed software and computer services stock specialising in data and AI has published its interim results

China tech champion sees its stock rally again following substantial first half loss - will we see more in 2025?

This week we are tipping a China-based pioneer in healthcare devices which you can wear to keep track of essential readings.

One Health Group improves earnings and expects to exceed its previous year-end forecast following resolution of the NHS junior doctors' strike

Canadian miner Brazil Potash aims to get an IPO away in New York, while drug maker Apotex may test market next year.

Fresh from our tour of Japan, we look at five of the top large cap stocks currently trading on the Tokyo Stock Exchange.

The integration of AI into drug discovery is reshaping the biotech and healthcare landscape. Here's how you can invest in these advancements

Biotech company Septerna is coming to NASDAQ, Swiggy cuts its IPO valuation and Hong Kong is back in business with Horizon Robotics IPO

Tecan Group's share price continues to fall, but is this true of the rest of the healthcare sector in Switzerland?

This guide is designed to help investors evaluate their exposure to the dynamic and rapidly evolving fields of Artificial Intelligence and robotics

Snowflake has taken a beating over the summer. Can this tech stock rally, or are there better options for investors?

Concerns still swirl around the Cerebras IPO due to the absence of the big tech banks, while London gets ready for Applied Nutrition.

Oxford Biodynamics reports increased orders for prostrate cancer test, but high cash-burn leads to strategic review and cost cutting measures

On the podcast this week we speak with legendary US money manager Cathie Wood, CEO of ARK Invest, about US equity markets.

A tech start up from Lithuania is pioneering a new AI-driven service to help with sorting and reusing unwanted LEGO bricks.

Perimeter Medical Imaging has a major sugar daddy but investors have been worried about his commitment to the stock: is he still on board?

Ryan Reynolds' ad company sits down with Morgan Stanley to talk IPO plans, while a $200m healthcare SPAC hits the market.